| Literature DB >> 26614367 |
Aaron I Vinik1, Celine Chaya2.
Abstract
Neuroendocrine tumors (NETs) are slow-growing neoplasms capable of storing and secreting different peptides and neuroamines. Some of these substances cause specific symptom complexes, whereas others are silent. They usually have episodic expression, and the diagnosis is often made at a late stage. Although considered rare, the incidence of NETs is increasing. For these reasons, a high index of suspicion is needed. In this article, the different clinical syndromes and the pathophysiology of each tumor as well as the new and emerging biochemical markers and imaging techniques that should be used to facilitate an early diagnosis, follow-up, and prognosis are reviewed.Entities:
Keywords: Biomarkers; Diagnosis; GEP-NETs; PNETs; Syndromes and their tumors
Mesh:
Substances:
Year: 2015 PMID: 26614367 DOI: 10.1016/j.hoc.2015.08.006
Source DB: PubMed Journal: Hematol Oncol Clin North Am ISSN: 0889-8588 Impact factor: 3.722